Biogen Selects Denmark's 'Medicon Valley' as Site for its First International Major Manufacturing Facility

16-May-2001 - Biogen, Inc. (Nasdaq: BGEN) today announced that it has purchased a 60-acre (243,000 m2) site with an option for an additional 36 acres (145,692 m2) in the Municipality of Hillerod, Denmark as the site of its first European major manufacturing facility. Biogen plans to invest $350 million or ...

Biogen Launches MSActiveSource.com

Personalized Site Features Daily Multiple Sclerosis Research Updates

28-Mar-2001 - Biogen, Inc. (Nasdaq: BGEN) announced the launch of MSActiveSource.com, a comprehensive Internet site for people living with multiple sclerosis (MS), their caregivers, and healthcare professionals. The new site offers personalized support and in-depth information to help better understand and ...

Biogen Names Patrick J. Purcell Vice President, Chief Information Officer

05-Feb-2001 - Biogen (Nasdaq: BGEN) today announced the appointment of Patrick J. Purcell to the newly created position of Vice President, Chief Information Officer. Mr. Purcell reports to James C. Mullen, Biogen's President and Chief Executive Officer. Mr. Purcell, 40, joins Biogen from Sprint, where he ...

New Study with Biogen's AVONEX(R) (Interferon Beta-1a)

18-Jan-2001 - Biogen, Inc. (Nasdaq: BGEN) announced today that its IMPACT study with AVONEX(R) (Interferon beta-1a) in secondary progressive multiple sclerosis (MS) achieved its primary endpoint. Treatment with AVONEX reduced the progression of disability of secondary progressive MS by 27 percent versus ...